Compare Dover Corp (DOV) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dover Corp vs Tempus AI — how do they compare? Dover Corp trades at $190.16 (market cap $25.36B), while Tempus AI trades at $69.99 (market cap $12.77B). The key difference: Dover Corp is the larger of the two by market cap, and Dover Corp pays a 1.12% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dover Corp for 73 Days and Tempus AI for 22 Days on average.
| DOV | TEM | |
|---|---|---|
Market Cap | $25.36B | $12.77B |
Volume | 661,752 | 8,980,490 |
Sector | Industrials | Broad Market / Factor |
52-Week High | $233.31 | $99.28 |
52-Week Low | $161.16 | $41.55 |
Typical Hold Time | 73 Days | 22 Days |
Enterprise Value | $26.86B | $13.40B |
Dividend Yield | 1.12% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DOV trades at $188.96, down 1.52% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company maintains strong profitability with a net income margin of 13.48% and has beaten earnings estimates for three consecutive quarters. Recent news highlights product launches and strategic acquisitions, including the completion of the Cloeren acquisition in August 2026, supporting growth initiatives.
Analyst consensus is strongly bullish with a $243.20 price target, implying significant upside. Key risks include execution of acquisitions and macroeconomic pressures on industrial demand. The stock's valuation multiples appear reasonable relative to earnings growth, positioning it for potential recovery if operational momentum continues.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dover Corp
Dover is a diversified industrial manufacturing company with products and services that include digital printing for fast-moving consuming goods, marking and coding for the food and beverage industry, loaders for the waste collection industry, pumps for the transport of fluids, including petroleum and natural gas, and commercial refrigerators used in groceries and convenience stores. Most of the business operates in the United States. After the spinoff of Apergy, the company operates through five segments: engineered systems, clean energy and fueling solutions, imaging and identification, pumps and process solutions, and climate and sustainability technologies equipment.
Read more on DOV →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
